Clinical Practice Guidelines
EHA creates clinical practice Guidelines for diagnosis and treatment of hematologic diseases. This initiative started in 2019 with the establishment of the EHA Guidelines Committee and the definition of the EHA Methodology for Guidelines.
Since then, in addition to developing its own Guidelines, EHA Guidelines has established a framework for collaboration with ESMO (European Society for Medical Oncology) to produce Guidelines on hematologic malignancies, as well as on other hematologic diseases with EuNet-INNOCHRON, EuroBloodNet, British Society of Hematology (BSH), International Society of Amyloidosis (ISA), European Association for Haemophilia and Allied Disorders (EAHAD), and the International Society on Thrombosis and Haemostasis (ISTH). EHA further promotes strong collaboration with the EHA-SWGs and other medical societies and associations.
The Guidelines Committee has approved the following methodology documents:
For guidance regarding COVID-19, see FAQ by the EHA SWG on Infections
EHA has also initiated a series of online workshops dedicated to guidelines (produced or endorsed by EHA) for diagnosis and treatment of hematologic diseases. These workshops are aimed at disseminating good practices and knowledge with the help of patient cases, presentations and discussions with the guidelines’ authors and EHA experts.